bristoldrv Posted February 28, 2019 Report Share Posted February 28, 2019 Faber Report: Top Bristol-Myers shareholder doesn't back Celgene deal CNBCCNBC's David Faber reports on Bristol-Myers' top shareholder Wellington Management putting out a statement saying they do not back the biopharmaceutical ... View the full article Quote Link to comment Share on other sites More sharing options...